T-cell acute lymphoblastic leukemia pediatric · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Mitoxantrone, Asparaginase Erwinia chrysanthemi, Vincristine, Dexamethasone Variant #01 | — | R 8 543 | 28d | — | — | — | — | — |
Mitoxantrone, Pegaspargase, Vincristine, Dexamethasone Variant #01 | — | R 8 543 | 28d | — | — | — | — | — |
Nelarabine monotherapy Variant #01 Partial | — | — | 21d | — | — | — | — | — |
3 of 3 regimens shown